Lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathway

Ajello, 2002, Anti-invasive activity of bovine lactoferrin towards group A streptococci, Biochem. Cell Biol., 80, 119, 10.1139/o01-211 Baveye, 1999, Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process, Clin. Chem. Lab. Med., 37, 281, 10.1515/CCLM.1999.049 Boucher, 2002, Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae, J. Biol. Chem., 277, 15507, 10.1074/jbc.M200428200 Bu, 1998, Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family, Curr. Opin. Lipidol., 9, 149, 10.1097/00041433-199804000-00012 Cornish, 2004, Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo, Endocrinology, 145, 4366, 10.1210/en.2003-1307 Datta, 1999, Cellular survival: a play in three Akts, Genes Dev., 13, 2905, 10.1101/gad.13.22.2905 Fadok, 1992, Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages, J. Immunol., 148, 2207, 10.4049/jimmunol.148.7.2207 Fujita, 2004, Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats, Carcinogenesis, 25, 1961, 10.1093/carcin/bgh205 Fujita, 2004, Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat, Cancer Lett., 213, 21, 10.1016/j.canlet.2004.03.029 Gao, 2005, PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth, Mol. Cell., 18, 13, 10.1016/j.molcel.2005.03.008 Goetzl, 1998, Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate, FASEB J., 12, 1589, 10.1096/fasebj.12.15.1589 Gong, Y., Slee, R.B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A.M., Wang, H., Cundy, T., Glorieux, F.H., Lev, D., Zacharin, M., Oexle, K., Marcelino, J., Suwairi, W., Heeger, S., Sabatakos, G., Apte, S., Adkins, W.N., Allgrove, J., Arslan-Kirchner, M., Batch, J.A., Beighton, P., Black, G.C., Boles, R.G., Boon, L.M., Borrone, C., Brunner, H.G., Carle, G.F., Dallapiccola, B., De Paepe, A., Floege, B., Halfhide, M.L., Hall, B., Hennekam, R.C., Hirose, T., Jans, A., Juppner, H., Kim, C.A., Keppler-Noreuil, K., Kohlschuetter, A., LaCombe, D., Lambert, M., Lemyre, E., Letteboer, T., Peltonen, L., Ramesar, R.S., Romanengo, M., Somer, H., Steichen-Gersdorf, E., Steinmann, B., Sullivan, B., Superti-Furga, A., Swoboda, W., van den Boogaard, M.J., Van Hul, W., Vikkula, M., Votruba, M., Zabel, B., Garcia, T., Baron, R., Olsen, B.R., Warman, M.L.,Osteoporosis-Pseudoglioma Syndrome Collaborative G., 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell, 107, 513–523. Grey, 2001, Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not p42/44 mitogen-activated protein kinases, Endocrinology, 142, 1098, 10.1210/en.142.3.1098 Grey, 2004, The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells, Mol. Endocrinol., 18, 2268, 10.1210/me.2003-0456 Grey, 2002, The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase, Endocrinology, 143, 4755, 10.1210/en.2002-220347 Grey, 2003, Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells, Endocrinology, 144, 4886, 10.1210/en.2003-0350 Herz, 2000, Cellular signalling by lipoprotein receptors, Curr. Opin. Lipidol., 11, 161, 10.1097/00041433-200004000-00009 Jilka, 1999, Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone, J. Clin. Invest., 104, 439, 10.1172/JCI6610 Legrand, 2004, Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells, Eur. J. Biochem., 271, 303, 10.1046/j.1432-1033.2003.03929.x Loukinova, 2002, Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function between LRP and the PDGF, J. Biol. Chem., 277, 15499, 10.1074/jbc.M200427200 Manolagas, 2000, Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis, Endocr. Rev., 21, 115, 10.1210/er.21.2.115 Moolenaar, 1999, Bioactive lysophospholipids and their G protein-coupled receptors, Exp. Cell Res., 253, 230, 10.1006/excr.1999.4702 Niemeier, 2005, Expression of LRP1 by human osteoblasts: a mechanism for the delivery of lipoproteins and vitamin K-1 to bone, J. Bone Miner. Res., 20, 283, 10.1359/JBMR.041102 Strickland, 2002, Diverse roles for the LDL receptor family, Trends Endocrinol. Metab., 13, 66, 10.1016/S1043-2760(01)00526-4 Suzuki, 2002, Characterization of mammalian receptors for lactoferrin, Biochem. Cell Biol., 80, 75, 10.1139/o01-228 Suzuki, 2001, Molecular cloning and functional expression of a human intestinal lactoferrin receptor, Biochemistry (Mosc.), 40, 15771, 10.1021/bi0155899 Takayama, 2003, Low density lipoprotein receptor-related protein (LRP) is required for lactoferrin-enhanced collagen gel contractile activity of human fibroblasts, J. Biol. Chem., 278, 22112, 10.1074/jbc.M300894200 Talukder, 2003, Characteristics of lactoferrin receptor in bovine intestine: higher binding activity to the epithelium overlying Peyer's patches, J. Vet. Med., Ser. A, 50, 123, 10.1046/j.1439-0442.2003.00512.x Tinari, 2005, Inhibitory activity of bovine lactoferrin against echovirus induced programmed cell death in vitro, Int. J. Antimicrob. Agents, 25, 433, 10.1016/j.ijantimicag.2005.02.011 Tsuda, 2002, Cancer prevention by bovine lactoferrin and underlying mechanisms—a review of experimental and clinical studies, Biochem. Cell Biol., 80, 131, 10.1139/o01-239 Tsuda, 2000, Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals, Biofactors, 12, 83, 10.1002/biof.5520120113 Weinstein, 1998, Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone, J. Clin. Invest., 102, 274, 10.1172/JCI2799 Weinstein, 2000, Apoptosis and osteoporosis, Am. J. Med., 108, 153, 10.1016/S0002-9343(99)00420-9 Willnow, 1992, Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance, J. Biol. Chem., 267, 26172, 10.1016/S0021-9258(18)35732-6 Yang, 2004, Tyrosine phosphorylation of the LDL receptor-related protein (LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation, FASEB J., 18, 1920, 10.1096/fj.04-2357fje Yang, 2005, G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the beta-catenin pathway, Proc. Natl. Acad. Sci. U.S.A., 102, 6027, 10.1073/pnas.0501535102